Home
About OBIO
OBIO Governance
Our Mandate
Board of Directors
Founding Sponsors
Contact Us
Membership
Sponsorship
Featured Articles
OBIO News & Events
Industry News
Press Releases
Reports
Founding Sponsors
Gold
Amgen
Equicom
HealthComm
Silver
Merck Frosst
Rx&D
Gowlings
PwC
Bronze
RBC
Astra Zeneca
Dalton Pharma Services
Dalton Medicinal Chemistry
Pfizer
Supporter
VWR
Recent Posts
Q2 2010 Canadian Healthcare Review
Ten Years After – Looking Back At A Biotech Boom
New economic strategy team to be charged with developing, guiding growth for Ontario bioscience industry
The Burrill Report – Canadian Edition, April 2010
ONTARIO’S LIFE SCIENCES COMMERCIALIZATION STRATEGY
New strategy, special financing to advance disease treatment, prevention or diagnosis programs of Ontario bioscience companies
Q1 2010 Canadian Healthcare Review
CEOs Speak Out About Issues Affecting Their Ability to Grow in 2010 and Beyond
Discussion Notes: Quebec/Ontario Bioscience CEO Dinner, April 6, 2010
BURRILL CANADIAN BIOTECH NEWS
Tags
access to capital
BIOTECanada
biotechnology industry
government of ontario
healthcare
obio
ontario
operations
people